title: Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports.
abstract: OBJECTIVE
  A recent case report suggested that olanzapine resulted in improved weight gain and maintenance, as well as decreased anxiety and agitation, for two hospitalized inpatients with anorexia nervosa (AN). However, a subsequent larger case study did not show a relationship between the use of olanzapine and rate of weight gain among a primarily adult population. The aim of this case report was to clinically examine the therapeutic benefit and tolerability of olanzapine as an adjunctive treatment for four children with AN in a pediatric inpatient setting.
  
  
  RESULTS
  Olanzapine use was associated with considerable weight gain and maintenance, with an average rate of weight gain during hospitalization of 0.99 kg per week. In addition to weight gain, olanzapine was associated with a clinically notable decrease in levels of agitation and premeal anxiety and almost immediate improvement in sleep, general functioning, and overall compliance with treatment. Olanzapine was also well tolerated in these young patients.
  
  
  CONCLUSIONS
  These case report findings warrant more controlled research, including randomized controlled studies, to better determine the therapeutic benefits and safety of olanzapine use in children with AN.
authors.affiliation: Department of Psychiatry, Children's Hospital of Eastern Ontario, Ottawa, Canada.
authors.forename: Ahmed
authors.initials: A
authors.lastname: Boachie
authors.forename: Gary S
authors.initials: GS
authors.lastname: Goldfield
authors.forename: Wendy
authors.initials: W
authors.lastname: Spettigue
mesh_terms: D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000523:psychology / Q000534:rehabilitation*; D001569:Benzodiazepines; D015992:Body Mass Index; D002648:Child; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D001569:Benzodiazepines; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors